Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:31:23 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



Q:BIOL - BIOLASE INC - http://www.biolase.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BIOL - Q1.40.143·0.16220.10.1451    32.09  0.1251May 0306:3115 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-06 06:31U:BIOLNews ReleaseBIOLASE to Report First Quarter 2024 Results on May 13, 2024
2024-03-21 16:08U:BIOLNews ReleaseBiolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
2024-03-14 06:31U:BIOLNews ReleaseBIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
2024-02-22 06:42U:BIOLNews ReleaseBiolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
2024-02-20 06:32U:BIOLNews ReleaseBiolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
2024-02-15 14:46U:BIOLNews ReleaseBIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
2024-02-14 06:31U:BIOLNews ReleaseBIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
2024-02-13 09:17U:BIOLNews ReleaseBIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
2024-01-29 06:30U:BIOLNews ReleaseBIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024
2024-01-08 16:05U:BIOLNews ReleaseBIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023
2024-01-03 16:05U:BIOLNews ReleaseBIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
2023-12-14 16:05U:BIOLNews ReleaseBIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
2023-12-12 16:05U:BIOLNews ReleaseBIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial
2023-12-06 13:46U:BIOLNews ReleaseBIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2023-11-09 16:05U:BIOLNews ReleaseBIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES
2023-11-08 06:30U:BIOLNews ReleaseLandmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR ‚ ® Perio Protocol
2023-11-07 16:05U:BIOLNews ReleaseBIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023
2023-10-18 08:00U:BIOLNews ReleaseSWK Holdings Highlights Recent Achievements and Provides Portfolio Update
2023-09-18 16:30U:BIOLNews ReleaseBIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
2023-09-13 23:16U:BIOLNews ReleaseBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants